Stanley E. Waintraub

401 total citations
21 papers, 290 citations indexed

About

Stanley E. Waintraub is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Stanley E. Waintraub has authored 21 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 9 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Stanley E. Waintraub's work include Cancer Treatment and Pharmacology (5 papers), Breast Cancer Treatment Studies (4 papers) and Cancer Genomics and Diagnostics (4 papers). Stanley E. Waintraub is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Breast Cancer Treatment Studies (4 papers) and Cancer Genomics and Diagnostics (4 papers). Stanley E. Waintraub collaborates with scholars based in United States and China. Stanley E. Waintraub's co-authors include Andrew L. Pecora, Stuart L. Goldberg, Robert Alter, Scott D. Rowley, Robert A. Preti, Jerome I. Brody, Saranya Chumsri, Laurie M. Gay, Vincent A. Miller and Jeffrey S. Ross and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Stanley E. Waintraub

21 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stanley E. Waintraub United States 7 153 56 53 46 40 21 290
Mufaddal Moonim United Kingdom 10 94 0.6× 62 1.1× 50 0.9× 45 1.0× 55 1.4× 37 376
Anand Pathak United States 11 134 0.9× 53 0.9× 39 0.7× 43 0.9× 42 1.1× 25 395
Anne Tallet France 13 238 1.6× 75 1.3× 49 0.9× 30 0.7× 59 1.5× 37 566
B.K. Amo-Takyi Germany 11 101 0.7× 85 1.5× 53 1.0× 13 0.3× 23 0.6× 19 346
Mridu Manjari India 12 122 0.8× 78 1.4× 33 0.6× 16 0.3× 18 0.5× 80 350
Jérôme Chetritt France 10 82 0.5× 39 0.7× 41 0.8× 32 0.7× 18 0.5× 32 474
Yandong Shen Australia 11 78 0.5× 20 0.4× 67 1.3× 118 2.6× 32 0.8× 29 396
Marta Sonia González Spain 11 62 0.4× 37 0.7× 39 0.7× 61 1.3× 116 2.9× 38 280
Fanny Drieux France 9 87 0.6× 30 0.5× 109 2.1× 53 1.2× 18 0.5× 24 236
Pilar Nava-Parada United States 9 90 0.6× 44 0.8× 54 1.0× 79 1.7× 27 0.7× 14 286

Countries citing papers authored by Stanley E. Waintraub

Since Specialization
Citations

This map shows the geographic impact of Stanley E. Waintraub's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanley E. Waintraub with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanley E. Waintraub more than expected).

Fields of papers citing papers by Stanley E. Waintraub

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stanley E. Waintraub. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanley E. Waintraub. The network helps show where Stanley E. Waintraub may publish in the future.

Co-authorship network of co-authors of Stanley E. Waintraub

This figure shows the co-authorship network connecting the top 25 collaborators of Stanley E. Waintraub. A scholar is included among the top collaborators of Stanley E. Waintraub based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stanley E. Waintraub. Stanley E. Waintraub is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Albitar, Maher, Andrew Ip, Sally Agersborg, et al.. (2024). Using cell-free RNA in monitoring immune system and the demonstration of significant systemic deficiency in lymphoid and myeloid biomarkers in patients with cancer.. Journal of Clinical Oncology. 42(16_suppl). 3048–3048. 1 indexed citations
2.
Albitar, Maher, Hong Zhang, Andrew Ip, et al.. (2023). Combining cell-free RNA with cell-free DNA in liquid biopsy for hematologic and solid tumors. Heliyon. 9(5). e16261–e16261. 14 indexed citations
3.
Zhang, Hong, Andrew Ip, Andrew L. Pecora, et al.. (2023). Predicting PD-L1 Status in Solid Tumors Using Transcriptomic Data and Artificial Intelligence Algorithms. Journal of Immunotherapy. 47(1). 10–15. 2 indexed citations
4.
Albitar, Maher, Hong Zhang, Andrew L. Pecora, et al.. (2023). Homologous Recombination Abnormalities Associated With BRCA1/2 Mutations as Predicted by Machine Learning of Targeted Next-Generation Sequencing Data. Breast Cancer Basic and Clinical Research. 17. 771937539–771937539. 4 indexed citations
5.
Albitar, Maher, Hong Zhang, Andrew Ip, et al.. (2022). Cell-free RNA in liquid biopsy and biomarkers profiling of hematologic and solid tumors.. Journal of Clinical Oncology. 40(16_suppl). 3047–3047. 2 indexed citations
6.
Albitar, Maher, Hong Zhang, Andrew Ip, et al.. (2022). Combining cell-free RNA (cfRNA) with cell-free total nucleic acid (cfTNA) as a new paradigm for liquid biopsy.. Journal of Clinical Oncology. 40(16_suppl). 3048–3048. 1 indexed citations
7.
Goldberg, Stuart L., Lisa Latts, Deena Graham, et al.. (2019). Differential impact of cognitive computing augmented by real world evidence on novice and expert oncologists. Cancer Medicine. 8(15). 6578–6584. 13 indexed citations
8.
Graham, Deena, Stanley E. Waintraub, Andrew D. Norden, et al.. (2018). Are treatment recommendations provided by cognitive computing supported by real world data (Watson for Oncology with Cota RWE) concordant with expert opinions?. Annals of Oncology. 29. viii571–viii571. 1 indexed citations
9.
Waintraub, Stanley E., et al.. (2017). Real-world economic value of a 21-gene assay in early-stage breast cancer.. PubMed. 23(12). e416–e420. 4 indexed citations
10.
11.
Ross, Jeffrey S., Laurie M. Gay, Kai Wang, et al.. (2016). Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti‐HER2 targeted therapies. Cancer. 122(17). 2654–2662. 59 indexed citations
12.
13.
Overmoyer, Beth, Stanley E. Waintraub, P. Kaufman, et al.. (2005). Phase II trial of KOS-862 (epothilone D) in anthracycline and taxane pretreated metastatic breast cancer. Journal of Clinical Oncology. 23(16_suppl). 778–778. 17 indexed citations
14.
15.
Agress, Harry, et al.. (2002). Colonic adenomas detected by 18F-FDG PET. Gastrointestinal Endoscopy. 56(5). 734–734. 3 indexed citations
16.
17.
Waintraub, Stanley E. & Jerome I. Brody. (2000). Use of anti-D in immune thrombocytopenic purpura as a means to prevent splenectomy: Case reports from two university hospital medical centers. Seminars in Hematology. 37(1 Suppl 1). 45–49. 10 indexed citations
18.
Waintraub, Stanley E. & Ira I. Sussman. (1985). The destabilization of factor VIII by a vitamin K dependent protein. British Journal of Haematology. 59(4). 579–586. 4 indexed citations
19.
Berger, Stephen A., et al.. (1981). Penetration of antibiotics into decubitus ulcers. Journal of Antimicrobial Chemotherapy. 7(2). 193–195. 15 indexed citations
20.
Waintraub, Stanley E., et al.. (1980). Fatal amebiasis; with toxic megacolon and hepatic abscess.. PubMed. 80(9). 1431–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mufaddal Moonim Breakdown of academic impact, for papers by Anand Pathak Breakdown of academic impact, for papers by Anne Tallet Breakdown of academic impact, for papers by B.K. Amo-Takyi Breakdown of academic impact, for papers by Mridu Manjari Breakdown of academic impact, for papers by Jérôme Chetritt Breakdown of academic impact, for papers by Yandong Shen Breakdown of academic impact, for papers by Marta Sonia González Breakdown of academic impact, for papers by Fanny Drieux Breakdown of academic impact, for papers by Pilar Nava-Parada
Rankless by CCL
2026